The significant rarity of thyroid SCC and a surprisingly high prevalence of Chr 3p LOH in DTC (40% of PTC and 67% of FTC) [74] nonetheless predicts that pathogenic BAP1 mutations must be rare events in thyroid malignancy. Here, BAP1 is linked to thyroid cancer, nonmedullary, 2.